Role of the 75-kDa tumor necrosis factor receptor: inhibition of early hematopoiesis.
暂无分享,去创建一个
E. Smeland | D. Goeddel | S. Jacobsen | M. Rothe | L. Slørdal | F. Jacobsen | L. Rusten | O. P. Veiby | L. Rusten
[1] S. Jacobsen,et al. Novel role of interleukin 7 in myelopoiesis: stimulation of primitive murine hematopoietic progenitor cells , 1993, The Journal of experimental medicine.
[2] L. Tartaglia,et al. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. , 1993, The Journal of biological chemistry.
[3] F. Balkwill. Improving on the formula , 1993, Nature.
[4] Jan Tavernier,et al. Human TNF mutants with selective activity on the p55 receptor , 1993, Nature.
[5] L. Tartaglia,et al. Antiviral activity of tumor necrosis factor is signaled through the 55-kDa type I TNF receptor [corrected]. , 1992, Journal of Immunology.
[6] S. Jacobsen,et al. Tumor necrosis factor alpha directly and indirectly regulates hematopoietic progenitor cell proliferation: role of colony-stimulating factor receptor modulation , 1992, The Journal of experimental medicine.
[7] G. Johnson,et al. Rhodamine123 reveals heterogeneity within murine Lin-, Sca-1+ hemopoietic stem cells , 1992, The Journal of experimental medicine.
[8] L. Tartaglia,et al. Two TNF receptors. , 1992, Immunology today.
[9] L. Tartaglia,et al. The two different receptors for tumor necrosis factor mediate distinct cellular responses. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[10] J. Banchereau,et al. Potentiation of early hematopoiesis by tumor necrosis factor-alpha is followed by inhibition of granulopoietic differentiation and proliferation. , 1991, Blood.
[11] E. Chen,et al. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[12] I. Touw,et al. Tumor necrosis factor regulates the expression of granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors on human acute myeloid leukemia cells. , 1991, Blood.
[13] H. Loetscher,et al. Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors , 1990, The Journal of experimental medicine.
[14] G. Spangrude,et al. Resting and activated subsets of mouse multipotent hematopoietic stem cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[15] G. Spangrude,et al. A simplified method for enrichment of mouse hematopoietic stem cells. , 1990, Experimental hematology.
[16] H. Holtmann,et al. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. , 1990, The Journal of biological chemistry.
[17] J. Banchereau,et al. Tumor necrosis factor-alpha strongly potentiates interleukin-3 and granulocyte-macrophage colony-stimulating factor-induced proliferation of human CD34+ hematopoietic progenitor cells. , 1990, Blood.
[18] C. Smith,et al. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. , 1990, Science.
[19] H. Tabuchi,et al. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor , 1990, Cell.
[20] G. Wong,et al. Molecular cloning and expression of a receptor for human tumor necrosis factor , 1990, Cell.
[21] H. Schoenfeld,et al. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[22] H. Loetscher,et al. Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor , 1990, The Journal of experimental medicine.
[23] P. Quesenberry,et al. Colony-forming cells with high proliferative potential (HPP-CFC). , 1990, International journal of cell cloning.
[24] S. Cannistra,et al. Regulation of surface expression of the granulocyte/macrophage colony-stimulating factor receptor in normal human myeloid cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[25] M. Moore,et al. Modulation of colony-stimulating factor-1 receptors on macrophages by tumor necrosis factor. , 1989, Journal of immunology.
[26] B. Beutler,et al. The biology of cachectin/TNF--a primary mediator of the host response. , 1989, Annual review of immunology.
[27] L. Guilbert,et al. Synergistic stimulation of macrophage proliferation by the monokines tumor necrosis factor-alpha and colony-stimulating factor 1. , 1989, Blood.
[28] I. Weissman,et al. Purification and characterization of mouse hematopoietic stem cells. , 1988, Science.
[29] D. Williams,et al. Effects of hematopoietic suppressor molecules on the in vitro proliferation of purified murine granulocyte-macrophage progenitor cells. , 1988, Cancer research.
[30] G. Trinchieri,et al. Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells. , 1988, Experimental hematology.
[31] H. Koeffler,et al. Recombinant human TNF alpha stimulates production of granulocyte colony- stimulating factor , 1987 .
[32] U. Gullberg,et al. Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. Relationship to cell surface receptor. , 1986, The Journal of clinical investigation.
[33] H. Koeffler,et al. Recombinant human TNF induces production of granulocyte–monocyte colony-stimulating factor , 1986, Nature.
[34] D. Williams,et al. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. , 1986, Journal of immunology.
[35] L. Chess,et al. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1 , 1986, The Journal of experimental medicine.